524 related articles for article (PubMed ID: 28143772)
21. Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma.
Bansal S; Berk M; Alkhouri N; Partrick DA; Fung JJ; Feldstein A
J Surg Res; 2014 Jan; 186(1):29-38. PubMed ID: 24135379
[TBL] [Abstract][Full Text] [Related]
22. Insulin activates hepatic Wnt/β-catenin signaling through stearoyl-CoA desaturase 1 and Porcupine.
Cabrae R; Dubuquoy C; Caüzac M; Morzyglod L; Guilmeau S; Noblet B; Fève B; Postic C; Burnol AF; Moldes M
Sci Rep; 2020 Mar; 10(1):5186. PubMed ID: 32198362
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
[TBL] [Abstract][Full Text] [Related]
24. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
25. LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
Chen Z; Gao Y; Yao L; Liu Y; Huang L; Yan Z; Zhao W; Zhu P; Weng H
Oncogene; 2018 Jun; 37(23):3098-3112. PubMed ID: 29535420
[TBL] [Abstract][Full Text] [Related]
26. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
[TBL] [Abstract][Full Text] [Related]
27. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
[TBL] [Abstract][Full Text] [Related]
28. TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation.
Lettini G; Condelli V; Pietrafesa M; Crispo F; Zoppoli P; Maddalena F; Laurenzana I; Sgambato A; Esposito F; Landriscina M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065966
[TBL] [Abstract][Full Text] [Related]
29. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
[TBL] [Abstract][Full Text] [Related]
30. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2
Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K
Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074
[TBL] [Abstract][Full Text] [Related]
31. GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6.
Xiong H; Xiao H; Luo C; Chen L; Liu X; Hu Z; Zou S; Guan J; Yang D; Wang K
Exp Cell Res; 2019 Oct; 383(1):111493. PubMed ID: 31310747
[TBL] [Abstract][Full Text] [Related]
32. Human antigen R contributes to hepatic stellate cell activation and liver fibrosis.
Woodhoo A; Iruarrizaga-Lejarreta M; Beraza N; García-Rodríguez JL; Embade N; Fernández-Ramos D; Martínez-López N; Gutiérrez-De Juan V; Arteta B; Caballeria J; Lu SC; Mato JM; Varela-Rey M; Martínez-Chantar ML
Hepatology; 2012 Nov; 56(5):1870-82. PubMed ID: 22576182
[TBL] [Abstract][Full Text] [Related]
33. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
Dou C; Liu Z; Tu K; Zhang H; Chen C; Yaqoob U; Wang Y; Wen J; van Deursen J; Sicard D; Tschumperlin D; Zou H; Huang WC; Urrutia R; Shah VH; Kang N
Gastroenterology; 2018 Jun; 154(8):2209-2221.e14. PubMed ID: 29454793
[TBL] [Abstract][Full Text] [Related]
34. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
35. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
[TBL] [Abstract][Full Text] [Related]
36. Infection-induced signals generated at the plasma membrane epigenetically regulate Wnt signaling
Ahmed I; Roy BC; Rao Jakkula LUM; Subramaniam D; Dandawate P; Anant S; Sampath V; Umar S
J Biol Chem; 2020 Jan; 295(4):1021-1035. PubMed ID: 31836665
[TBL] [Abstract][Full Text] [Related]
37. Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop.
Lin XH; Liu HH; Hsu SJ; Zhang R; Chen J; Chen J; Gao DM; Cui JF; Ren ZG; Chen RX
J Exp Clin Cancer Res; 2020 Apr; 39(1):64. PubMed ID: 32293507
[TBL] [Abstract][Full Text] [Related]
38. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
[TBL] [Abstract][Full Text] [Related]
39. Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.
Chao HM; Huang HX; Chang PH; Tseng KC; Miyajima A; Chern E
Oncotarget; 2017 Jan; 8(2):2604-2616. PubMed ID: 27911878
[TBL] [Abstract][Full Text] [Related]
40. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.
Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK
J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
